Involvement of the Gab2 scaffolding adapter in type I interferon signalling

被引:12
作者
Baychelier, Florence
Nardeux, Pierre-Claude
Cajean-Feroldi, Chantal
Ermonval, Myriam
Guymarho, Jacqueline
Tovey, Michaeel G.
Eid, Pierre
机构
[1] CNRS, FRE 2937, Lab Oncol Virale, F-94801 Villejuif, France
[2] CNRS, FRE 2937, Lab Differenciat Cellulaire & Prions, F-94801 Villejuif, France
关键词
interferon-receptor; gab2-mutagenesis; phosphorylation; proteomics;
D O I
10.1016/j.cellsig.2007.05.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interferons (IFNs) are pleiotropic cytokines involved in the regulation of physiological and pathological processes. Upon interaction with their specific receptors, IFNs activate the Jak/STAT signalling pathway. Numerous studies suggest, however, that the classical Jak/STAT pathway cannot alone account for the wide range of IFN's biological effects. To better understand the role of alternative signalling pathways in the type I IFNs response, we analyzed novel tyrosine-phosphorylated proteins following IFN-alpha 2 stimulation. We showed for the first time that the Grb2-associated binder 2 (Gab2) protein is differentially phosphorylated upon the IFN subtype employed and the cells stimulated. We demonstrated that IFNAR1 physically interacts with Gab2. Moreover, the cellular content of Gab2 varies as a function of IFN receptor chain expression levels, and in particular of the ratio of IFNAR1 to IFNAR2, suggesting that Gab2 and IFNAR2 compete for interaction with IFNAR1. Analysis of Gab2 deletion mutants indicates that IFNAR1 might interact with a Gab2 region containing p85-P13'kinase binding sites. Our results shed new light on recent data involving both Gab2 and type I IFNs in osteoclastogenesis and oncogenesis. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:2080 / 2087
页数:8
相关论文
共 35 条
  • [11] The 'Gab' in signal transduction
    Gu, HH
    Neel, BG
    [J]. TRENDS IN CELL BIOLOGY, 2003, 13 (03) : 122 - 130
  • [12] Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation
    Gu, HH
    Pratt, JC
    Burakoff, SJ
    Neel, BG
    [J]. MOLECULAR CELL, 1998, 2 (06) : 729 - 740
  • [13] HOPKINS SJ, 1988, CLIN EXP IMMUNOL, V73, P88
  • [14] Inquiring into the differential action of interferons (IFNs):: an IFN-α2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-β
    Jaitin, DA
    Roisman, LC
    Jaks, E
    Gavutis, M
    Pichler, J
    Van der Heyden, J
    Uze, G
    Schreiber, G
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (05) : 1888 - 1897
  • [15] Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives
    Krause, CD
    Pestka, S
    [J]. PHARMACOLOGY & THERAPEUTICS, 2005, 106 (03) : 299 - 346
  • [16] Kumar KGS, 2003, EMBO J, V22, P5480
  • [17] The gift of gab
    Liu, Y
    Rohrschneider, LR
    [J]. FEBS LETTERS, 2002, 515 (1-3): : 1 - 7
  • [18] PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2
    Lynch, DK
    Daly, RJ
    [J]. EMBO JOURNAL, 2002, 21 (1-2) : 72 - 82
  • [19] The p38 MAPK pathway mediates the growth inhibitory effects of interferon-α in BCR-ABL-expressing cells
    Mayer, IA
    Verma, A
    Grumbach, IM
    Uddin, S
    Lekmine, F
    Ravandi, F
    Majchrzak, B
    Fujita, S
    Fish, EN
    Platanias, LC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) : 28570 - 28577
  • [20] BINDING OF I-125-LABELED HUMAN ALPHA-INTERFERON TO HUMAN LYMPHOID-CELLS
    MOGENSEN, KE
    BANDU, MT
    VIGNAUX, F
    AGUET, M
    GRESSER, I
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1981, 28 (05) : 575 - 582